Avisi

343 posts

Avisi banner
Avisi

Avisi

@avisi_tech

Working on a nanotech defense against blindness from glaucoma. #VisiPlate 💫

Redwood City, CA Katılım Haziran 2019
572 Takip Edilen301 Takipçiler
Avisi retweetledi
Penn Engineering
Penn Engineering@PennEngineers·
Born from collaboration between Penn Engineering and Wharton, @avisi_tech, founded by Wharton alumna Rui Jing (@Rj_sapientia) (W’18), has achieved a major milestone with FDA approval to begin its clinical trial studying a novel approach to glaucoma treatment. What began as a Penn student startup has grown into a pioneering medical device company shaped by collaboration across @Wharton, Penn Engineering, @PennMedicine and @PennLaw. “Our story is one of true interdisciplinary innovation,” said Jiang. “From founding Avisi at Penn in 2017 to collaborating with glaucoma experts at Scheie Eye Institute, Penn has been an important element of our success.” Today, Avisi continues its R&D at Penn’s Singh Center for Nanotechnology as it advances the SAPPHIRE clinical trial of VisiPlate®, a device designed to treat open-angle glaucoma by managing intraocular pressure. prnewswire.com/news-releases/… Link to clinical trials: clinicaltrials.gov/study/NCT07220…
Penn Engineering tweet mediaPenn Engineering tweet mediaPenn Engineering tweet media
English
1
4
10
1.5K
Avisi
Avisi@avisi_tech·
We won the People’s Choice Award for Anterior Segment and Glaucoma at the 2025 @Eyecelerator conference ahead of @ARVOinfo. We’re honored to be recognized by the attendees of the conference for our contribution to innovation in ophthalmology.
Avisi tweet media
English
0
0
2
94
Avisi
Avisi@avisi_tech·
This year at the @Eyecelerator conference, Avisi’s CEO Rui Jing Jiang will present on VisiPlate during the company breakout session. Rui Jing's presentation will be held on Friday, May 2nd, from 1:30pm - 3:00pm MT, at the Grand Hyatt Deer Valley Hotel in Park City, Utah.
Avisi tweet media
English
0
0
2
100
Avisi
Avisi@avisi_tech·
Avisi’s CEO Rui Jing will be speaking at this year's @DeviceTalks in Boston, MA, hosted by @MedtechInnovator. DeviceTalks will be held on Wednesday, April 30th, at the Omni Boston Hotel. To learn more about Avisi Technologies or VisiPlate®, visit avisitech.com.
Avisi tweet media
English
0
0
3
74
Avisi
Avisi@avisi_tech·
Avisi’s Scientific Advisors, Eydie Miller-Ellis, MD of @ScheieEye and @PennMedicine, will give an oral presentation at the 40th @AGSDocs Annual Meeting. The paper is about VisiPlate® and will share 6-month results from the VITA Trial.
Avisi tweet media
English
0
1
4
148
Avisi
Avisi@avisi_tech·
As the holiday season approaches, we want to express our gratitude for everyone's support. We wish you all a new year filled with joy and success!
Avisi tweet media
English
0
0
0
48
Avisi
Avisi@avisi_tech·
American Diabetes Month is here, so Avisi is doing its part by spreading awareness for early detection. So, let’s discuss diabetes and eye exams further.
Avisi tweet mediaAvisi tweet mediaAvisi tweet mediaAvisi tweet media
English
0
1
1
106
Avisi
Avisi@avisi_tech·
We are excited to welcome Vidhya Vilupuru to the Avisi team as Vice President of Clinical Affairs. She will lead Avisi’s clinical strategy in the US and internationally. Vidhya brings 15 years of experience enabling the success of ophthalmic surgical innovations. Welcome, Vidhya!
Avisi tweet media
English
0
0
0
137
Avisi
Avisi@avisi_tech·
November is National Diabetes Month! Did you know that diabetic retinopathy can turn into a type of glaucoma, a leading cause of blindness? There are no early warning signs, which is why getting regular eye exams is so important. This November, we'll be sharing more information.
Avisi tweet media
English
0
0
0
80
Avisi
Avisi@avisi_tech·
The @aao_ophth conference is here, and we’re excited to see you this weekend at booth 1748 by the Networking Lounge! If you want to connect, comment below or email us at info@avisitech.com.
Avisi tweet media
English
0
1
1
104
Avisi
Avisi@avisi_tech·
Thank you, Dr. Kamat for supporting Avisi and VisiPlate. We appreciate your review and discussion of ongoing innovations in glaucoma. We look forward to sharing more about our trial results soon at @aao_ophth. glaucomaphysician.net/issues/2024/se…
Avisi tweet media
English
0
1
5
103
Avisi
Avisi@avisi_tech·
We can’t wait to see you in Chicago! The @aao_ophth conference starts October 18th and ends October 21st. You can find us at booth 1748 by the Networking Lounge - if you’d like to connect, comment below or email us at info@avisitech.com.
Avisi tweet media
English
0
0
1
55
Avisi
Avisi@avisi_tech·
@aao_ophth Chicago is coming up and Avisi will be there! This year's AAO conference starts October 18th and ends October 21st. We hope to see you during the Expo at booth 1748 by the Networking Lounge - if you’d like to connect, comment below or email us at info@avisitech.com.
Avisi tweet media
English
0
0
2
42
Avisi
Avisi@avisi_tech·
September 15 - October 15 is Hispanic Heritage Month. This year, we are highlighting 5 ways you can engage with the Hispanic community during their time of celebration.
Avisi tweet mediaAvisi tweet mediaAvisi tweet mediaAvisi tweet media
English
0
0
1
69
Avisi
Avisi@avisi_tech·
Thank you, Dr.@SameerTrikha , for your support. We are excited about the bright future that these surgeons will bring to glaucoma patients worldwide.
Avisi tweet media
English
0
0
5
116
Avisi
Avisi@avisi_tech·
We at Avisi wish you and your loved ones a Happy Mid-Autumn Festival filled with health and happiness! 🐰 🥮
Avisi tweet media
English
0
0
1
57
Avisi
Avisi@avisi_tech·
September is healthy aging month, and we want to share some tips for maintaining healthy eyes as you age. By taking steps now to preserve your long-term eye health, you’ll maintain your quality of life.
Avisi tweet mediaAvisi tweet mediaAvisi tweet mediaAvisi tweet media
English
0
0
0
58
Avisi
Avisi@avisi_tech·
August is National Eye Exam Month! Did you know that by going for an eye exam, your ophthalmologist could discover many health conditions unrelated to visual health? Here are six conditions an eye professional could find.
Avisi tweet media
English
0
0
0
45